Thomas Herrmann

Active 1979–2025

379
Papers
18,459
Citations
80
h-index
218
i10-index

Citations

Citations per year for Thomas Herrmann1979: 2 citations1987: 1 citations1989: 5 citations1990: 4 citations1991: 5 citations1992: 3 citations1993: 12 citations1994: 6 citations1995: 9 citations1996: 8 citations1997: 14 citations1998: 36 citations1999: 40 citations2000: 21 citations2001: 24 citations2002: 44 citations2003: 58 citations2004: 63 citations2005: 76 citations2006: 103 citations2007: 109 citations2008: 125 citations2009: 147 citations2010: 140 citations2011: 153 citations2012: 178 citations2013: 191 citations2014: 147 citations2015: 140 citations2016: 172 citations2017: 166 citations2018: 163 citations2019: 420 citations2020: 664 citations2021: 548 citations2022: 430 citations2023: 374 citations2024: 624 citations2025: 389 citations2026: 23 citations1980–1986: no citations, so these years are not shown1988: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,296 citing papers, 16.7% of this breakdownGermany: 941 citing papers, 12.1% of this breakdownUnited Kingdom: 553 citing papers, 7.1% of this breakdownChina: 548 citing papers, 7.1% of this breakdownItaly: 490 citing papers, 6.3% of this breakdownFrance: 404 citing papers, 5.2% of this breakdownNetherlands: 282 citing papers, 3.6% of this breakdownSwitzerland: 274 citing papers, 3.5% of this breakdownCanada: 252 citing papers, 3.3% of this breakdownSpain: 205 citing papers, 2.6% of this breakdownAustria: 194 citing papers, 2.5% of this breakdownAustralia: 192 citing papers, 2.5% of this breakdown
0%16.7%Other 27.5%

Fields

  • Medicine48.1%
  • Immunology and Microbiology11.8%
  • Biochemistry, Genetics and Molecular Biology9.4%
  • Computer Science7.6%
  • Engineering4.5%
  • Business, Management and Accounting4.4%
  • Other14.2%

Topics

  • Immune Cell Function and Interaction3.9%
  • Urinary Bladder and Prostate Research3%
  • T-cell and B-cell Immunology2.8%
  • Kidney Stones and Urolithiasis Treatments2.3%
  • Prostate Cancer Diagnosis and Treatment2.1%
  • Immunotherapy and Immune Responses1.9%
  • Other84%

Coauthors

All papers

Open in search
  1. Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2016 cited by 494

  2. Keeping the organization in the loop: a socio-technical extension of human-centered artificial intelligence

    Authors: , - AI & Society, AI Soc. 2022 cited by 145

  3. A Tube-MPC Approach to Autonomous Multi-Vehicle Racing on High-Speed Ovals

    Authors: , , , - IEEE Transactions on Intelligent Vehicles, IEEE Trans. Intell. Veh. 2022 cited by 81

  4. Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset

    Authors: , , , , , , , , , , , , , , , , - Blood 2012 cited by 525

  5. Pressure matters: intrarenal pressures during normal and pathological conditions, and impact of increased values to renal physiology

    Authors: , , , - World Journal of Urology 2018 cited by 285

  6. Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms

    Authors: , , , , , , , , , , , , , - European Urology 2023 cited by 191

  7. Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing

    Authors: , , , , , , , , , , , , , , , , , , , , , - Immunity 2020 cited by 247

  8. Indy Autonomous Challenge - Autonomous Race Cars at the Handling Limits

    Authors: , , , , , , , , , , , , , , , , , - Proceedings 2022 cited by 52

  9. BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells

    Authors: , , , , , , , , , , , , , , , , - Cell Reports 2021 cited by 92

  10. Phosphoantigen sensing combines TCR-dependent recognition of the BTN3A IgV domain and germline interaction with BTN2A1

    Authors: , , , , , , , , , , - Cell Reports 2023 cited by 52

  11. A distinct topology of BTN3A IgV and B30.2 domains controlled by juxtamembrane regions favors optimal human γδ T cell phosphoantigen sensing

    Authors: , , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 49

  12. An International Collaborative Consensus Statement on En Bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus Meeting

    Authors: , , , , , , , , , , , , , , , , , , , , - European Urology 2020 cited by 129

  13. Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2014 cited by 414

  14. From BPH to male LUTS: a 20-year journey of the EAU guidelines

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthias Oelke, Jean de la Rosette - Prostate Cancer and Prostatic Diseases 2023 cited by 43

  15. Intervention user interfaces: a new interaction paradigm for automated systems

    Authors: , - interactions 2017 cited by 69

  16. Activation of Vγ9Vδ2 T Cells by NKG2D

    Authors: , , , , , - The Journal of Immunology 2005 cited by 305

  17. Ureteral stricture rate after endoscopic treatments for urolithiasis and related risk factors: systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Palle Jørn Sloth Osther, Ioannis Kartalas Goumas, Pietro Acquati, L. Ajayi, Pietro Diana, Paolo Casale, Nicolò Maria Buffi - World Journal of Urology 2024 cited by 65

  18. Butyrophilins: γδ T Cell Receptor Ligands, Immunomodulators and More

    Authors: , - Frontiers in Immunology 2022 cited by 61

  19. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , - The Lancet Oncology 2009 cited by 960

  20. Suction in Percutaneous Nephrolithotripsy: Evolution, Development, and Outcomes from Experimental and Clinical studies. Results from a Systematic Review

    Authors: , , , , , , , , , , , , , , , , - European Urology Focus 2023 cited by 51

  21. Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction

    Authors: , , , , , , - World Journal of Urology 2010 cited by 220

  22. Pressure matters 2: intrarenal pressure ranges during upper-tract endourological procedures

    Authors: , , , - World Journal of Urology 2018 cited by 143

  23. Evaluating Virtual Reality Simulations for Construction Safety Training

    Authors: , , , , , , - i-com 2022 cited by 22

  24. A Systematic Review of Patients’ Values, Preferences, and Expectations for the Diagnosis and Treatment of Male Lower Urinary Tract Symptoms

    Authors: , , , , , , , , , , , , , , - European Urology 2021 cited by 125